Gregory J. Flesher
Equibles does not estimate personal net worth.
About Gregory J. Flesher
Gregory J. Flesher was last confirmed as Board Member at OnKure Therapeutics, Inc. (OKUR) in a filing dated April 22, 2022. Earlier roles on record: Board Member and CEO at Eledon Pharmaceuticals, Inc. (ELDN) until September 4, 2020. OnKure Therapeutics, Inc. reported in an 8-K filed May 13, 2024 that Gregory J. Flesher resigned as executive officer. The proxy statement of OnKure Therapeutics, Inc. reports total compensation of $1,779,607 for Gregory J. Flesher in fiscal 2024, including a base salary of $453,365. Disclosed compensation is on record for 7 fiscal years.
“each of Mr. Flesher, Mr.Dorenbaum, and Ms. Hall are expected to resign as executive officers of Reneo.”
Affiliation history
-
Start not stated–2022-04-22
Last confirmed by a filing; no departure on record
-
Start not stated–2020-09-04
-
Start not stated–2020-09-04
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | OnKure Therapeutics, Inc. (OKUR) | Former President and Chief Executive Officer | $453,365 | $1,779,607 |
| 2023 | OnKure Therapeutics, Inc. (OKUR) | Former President and Chief Executive Officer | $563,942 | $569,704 |
| 2022 | OnKure Therapeutics, Inc. (OKUR) | President and Chief Executive Officer | $545,000 | $1,193,452 |
| 2021 | OnKure Therapeutics, Inc. (OKUR) | President and Chief Executive Officer | $475,000 | $5,369,470 |
| 2020 | OnKure Therapeutics, Inc. (OKUR) | Chief Executive Officer and President | $79,167 | $132,947 |
| 2020 | Eledon Pharmaceuticals, Inc. (ELDN) | Former Chief Executive Officer | $364,496 | $2,415,586 |
| 2019 | Eledon Pharmaceuticals, Inc. (ELDN) | Former Chief Executive Officer | $480,436 | $842,664 |
| 2018 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $459,865 | $943,081 |